Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
about
Hepatitis C virus core protein blocks interferon signaling by interaction with the STAT1 SH2 domainAntiviral activities of ISG20 in positive-strand RNA virus infectionsInhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis CRegulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-IThe antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5ALambda interferon inhibits hepatitis B and C virus replication.Stealth and cunning: hepatitis B and hepatitis C viruses.Detection of anti-hepatitis C virus effects of interferon and ribavirin by a sensitive replicon system.West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling.Analysis of in vitro replicated human hepatitis C virus (HCV) for the determination of genotypes and quasispeciesProduction of Infectious Hepatitis C Virus by Well-Differentiated, Growth-Arrested Human Hepatoma-Derived CellsSynergistic In Vitro Interactions between Alpha Interferon and Ribavirin against Bovine Viral Diarrhea Virus and Yellow Fever Virus as Surrogate Models of Hepatitis C Virus ReplicationNovel Alpha Interferon (IFN- ) Variant with Improved Inhibitory Activity against Hepatitis C Virus Genotype 1 Replication Compared to IFN- 2b Therapy in a Subgenomic Replicon SystemMathematical Modeling of Subgenomic Hepatitis C Virus Replication in Huh-7 CellsViral Determinants of Resistance to Treatment in Patients with Hepatitis CThe hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor mediated liver diseaseAnalysis of Ribavirin Mutagenicity in Human Hepatitis C Virus InfectionActivity of a Potent Hepatitis C Virus Polymerase Inhibitor in the Chimpanzee ModelMemory CD8+ T cells are required for protection from persistent hepatitis C virus infectionCytopathic and Noncytopathic Interferon Responses in Cells Expressing Hepatitis C Virus Subgenomic RepliconsDynamics of Subgenomic Hepatitis C Virus Replicon RNA Levels in Huh-7 Cells after Exposure to Nucleoside AntimetabolitesDiscovery and Characterization of Substituted Diphenyl Heterocyclic Compounds as Potent and Selective Inhibitors of Hepatitis C Virus ReplicationLack of response to exogenous interferon-α in the liver of chimpanzees chronically infected with hepatitis C virusMolecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796A Genetic Interaction between Hepatitis C Virus NS4B and NS3 Is Important for RNA ReplicationHepatitis C virus replicons: dinosaurs still in business?Combinations of 2'-C-methylcytidine analogues with interferon-alpha2b and triple combination with ribavirin in the hepatitis C virus replicon systemAntiviral activity and host gene induction by tamarin and marmoset interferon-α and interferon-γ in the GBV-B primary hepatocyte culture modelMechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop.Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola VirusMutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signalingAdaptive immune responses in acute and chronic hepatitis C virus infectionMechanism of action of interferon and ribavirin in treatment of hepatitis CmicroRNA-122 abundance in hepatocellular carcinoma and non-tumor liver tissue from Japanese patients with persistent HCV versus HBV infection.Severe fever with thrombocytopenia syndrome virus inhibits exogenous Type I IFN signaling pathway through its NSs invitroDifferential transcriptional responses to interferon-alpha and interferon-gamma in primary human hepatocytes.Interferon type I gene expression in chronic hepatitis C.Therapeutic implications of hepatitis C virus resistance to antiviral drugs.
P2860
Q24301056-8A9AB32D-8623-4D59-A0B8-F058DBD76438Q24305035-4AA48287-1C5B-436A-B8C6-63FB67B916EBQ24519072-FC5014B0-D3A1-4A4C-971D-B35868A4B761Q24530717-316DF1F7-BC51-46FD-86B6-880AAC0FA56BQ24556673-1273B3F5-5201-44AA-AD46-543F128B4A13Q24632380-29EB89CD-AA10-4028-A1CF-61D6C25BB530Q27469456-30DA3235-E15A-4D8B-A253-60BC9B68E4CDQ27470232-F939DEF9-7918-44BB-B2A9-DF6002E37260Q27472717-B5895837-6B4E-4628-B2EB-AAECB3E3A8D2Q27473048-C98D2C62-802B-4066-936C-740313CF8D98Q27477520-5D003663-B9EF-42D3-8B62-5B8E0F8AFF37Q27477544-C1135CB6-11F5-4C61-B061-5AE8CEA8AB64Q27477551-3568498F-E737-4717-B0F1-33AC045CC12BQ27477758-90009EB2-5048-481A-B832-BFAE7FBBF8F2Q27478039-DAA4DE44-567A-48DF-82BD-CC05F0DB0BC3Q27478062-9712A0BD-1F51-401F-AE8B-836DFDA8797DQ27478330-CBBF1575-9648-4DF3-9052-95F77530518FQ27480933-F3D946F0-6BFD-4248-8BF0-C480106EC8DEQ27484513-CA555B1B-7441-4EE5-9EE9-B461334FE567Q27485119-37BB8FB4-AB79-401A-86D5-772938E7A7B1Q27485424-607F48E4-212F-4F00-9CE7-44EA2D597AE0Q27485663-3B27E989-4C71-41FD-A987-09B139FD04B0Q27485724-F4477DB3-B7E9-44EC-9A17-A21372C293CCQ27486088-846A62F6-CF81-4040-A6E4-5CD875452FE7Q27486816-0866BB62-5208-4D9D-9D26-9146F92BF938Q27487128-D4B6E901-77BD-4656-9EAE-2B2F5668A6C5Q27488905-201070BE-9671-4D64-B871-0559939637BFQ27489596-73EF97B2-6E71-4258-BD87-13E62F1DD801Q27489800-3538DF3E-DF9E-4A41-9F64-78ED8AF64F15Q27490650-A264B3B3-4169-45E1-83A9-343D8F3C5E7EQ27490714-FCBC797E-CDD6-439B-A159-1FBB0B86B947Q28476736-C51C84E5-18F0-448D-A39F-F43A51982B82Q29614206-D5A32DD0-39E7-454D-B9C5-2A9FF25F9899Q29619722-880DD9ED-409A-4734-A0C2-526FD16C3E25Q29619805-AB0175A7-1D87-4433-A86B-1600846F41B9Q31141908-19882243-1264-4788-A86D-884B030C792CQ33439601-EFFD0088-3E46-4C54-8188-F424265EF0E8Q34163327-86A24D3C-37C6-4CA5-B06F-0BE4CF949BA7Q34328120-76B31669-305F-489B-A5F8-EAB3926A8C0AQ34409020-20DE7DDA-9A56-4C41-BD0E-846D100250D0
P2860
Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antiviral Effect and Virus-Hos ...... s C Virus Subgenomic Replicons
@nl
Antiviral effect and virus-hos ...... C virus subgenomic replicons.
@ast
Antiviral effect and virus-hos ...... C virus subgenomic replicons.
@en
type
label
Antiviral Effect and Virus-Hos ...... s C Virus Subgenomic Replicons
@nl
Antiviral effect and virus-hos ...... C virus subgenomic replicons.
@ast
Antiviral effect and virus-hos ...... C virus subgenomic replicons.
@en
prefLabel
Antiviral Effect and Virus-Hos ...... s C Virus Subgenomic Replicons
@nl
Antiviral effect and virus-hos ...... C virus subgenomic replicons.
@ast
Antiviral effect and virus-hos ...... C virus subgenomic replicons.
@en
P2093
P2860
P1433
P1476
Antiviral effect and virus-hos ...... C virus subgenomic replicons.
@en
P2093
Bernadette Guerra
Brad Pfeiffer
Catherine Bigger
Deborah Chavez
Devron R Averett
Lena Notvall
Robert E Lanford
P2860
P304
P356
10.1128/JVI.77.2.1092-1104.2003
P577
2003-01-01T00:00:00Z